LRRK2 and Parkinson disease: An elegant demonstration of the superiority of an isogenic cell line study design over a study design comparing iPSC lines from patients versus control individuals was provided by a recent study of a mutation in the LRRK2 gene, which is implicated in Parkinson disease (Reinhardt et al., 2013).